1-4 of 4
Varsha Gandhi, Ph.D
Close
Sort by
Journal Articles

Pim Kinase Inhibitor, SGI-1776, Induces Apoptosis in CLL Lymphocytes

Lisa S Chen, Ph.D, William G Wierda, M.D., Ph.D, Sanjeev Redkar, Ph.D, David J. Bearss, PhD, Varsha Gandhi, Ph.D
Journal: Blood
Blood (2008) 112 (11): 4199.
https://doi.org/10.1182/blood.V112.11.4199.4199
Published: 2008
Journal Articles

Deoxycytidine Kinase Genotype Influences Leukemia Cell Concentration of Cytarabine 5′-Triphosphate in Pediatric AML Patients.

Jatinder Lamba, PhD, Kristine Crews, Pharm. D, Stanley Pounds, Ph.D., Erin Schuetz, Ph.D., Varsha Gandhi, Ph.D., William Plunkett, Ph.D., Jeffrey Rubnitz, M.D., Ph.D., Raul Ribeiro, M.D
Journal: Blood
Blood (2007) 110 (11): 225.
https://doi.org/10.1182/blood.V110.11.225.225
Published: 2007
Journal Articles

Development of Forodesine Hydrochloride (FH), an Inhibitor of Purine Nucleoside Phosphorylase, for Patients with Chronic Lymphocytic Leukemia (CLL).

Kumudha Balakrishnan, PhD, Farhad Ravandi, M.D, Michael J. Keating, M.D, Varsha Gandhi, Ph.D
Journal: Blood
Blood (2005) 106 (11): 2119.
https://doi.org/10.1182/blood.V106.11.2119.2119
Published: 2005
Journal Articles

2 Chlorodeoxyadenosine (2-CdA) and Cytarabine (ara-C) Combination Is Effective and Safe in Idiopathic Hypereosinophilic Syndrome (HES).

Elias Jabbour, M.D., Srdan Verstovsek, M.D., Ph.D., Varsha Gandhi, Ph.D., M.S., B.S., Jorge Cortes, M.D., Francis Giles, M.D., Charles Koller, M.D., Susan O’Brien, M.D., William Plunkett, Ph.D., Guillermo Garcia-Manero, M.D., Ellen Jackson, Hagop Kantarjian, M.D., Michael Andreeff, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 4764.
https://doi.org/10.1182/blood.V104.11.4764.4764
Published: 2004